Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 5;13(3):916.
doi: 10.3390/jcm13030916.

The Impact of Extracorporeal Magnetic Stimulation as Addition to Mirabegron in Overactive Bladder Treatment in Women: A Single-Centre Randomized Sham-Controlled Study

Uros Bele  1   2 , Tamara Serdinšek  1   3 , Evgenija Homšak  1   4 , Igor But  1   3
Affiliations

The Impact of Extracorporeal Magnetic Stimulation as Addition to Mirabegron in Overactive Bladder Treatment in Women: A Single-Centre Randomized Sham-Controlled Study

Uros Bele et al. J Clin Med. .

Abstract

(1) Background: The purpose of our prospective, single-blinded, randomized, sham-controlled study was to investigate the effect of the additional extracorporeal magnetic stimulation (ExMI) to pharmacological treatment in overactive bladder syndrome (OAB) in women. (2) Methods: We recruited 56 women with OAB, who were allocated into two study groups: the active group received mirabegron 50 mg daily and a total of 16 sessions of ExMI in 8 weeks, whereas the sham group received mirabegron 50 mg daily and sham stimulation following the same treatment protocol. Treatment success was evaluated after 4 and 8 weeks. (3) Results: Both groups experienced significant reduction in daytime urinary frequency, nocturia, and number of weekly incontinence episodes after 8 weeks. There were no statistically significant differences in end-point daytime urinary frequency and nocturia between groups. However, the overall average reduction rate in weekly number of incontinence episodes was 43.7% in treatment group and 24.2% in the control group. The number of urinary incontinence episodes in the treatment and control group was reduced for 3.8 ± 11.8 vs. 2.5 ± 4.3 episodes at week 4 and additional 3.3 ± 6 vs. 0.4 ± 3.2 episodes at week 8, respectively (p = 0.013). Moreover, IIQ-7 score showed a significantly greater score reduction and patients' evaluated improvement of symptoms was higher in the active group. (4) Conclusions: The addition of ExMI to mirabegron in OAB treatment further improves the weekly incontinence episode reduction rate and also leads to grater improvement in symptoms.

Keywords: magnetic stimulation; mirabegron; overactive bladder; patient satisfaction; urge urinary incontinence; urgency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of patient enrolment and the follow-up process.
Figure 2
Figure 2
Decrease in number of weekly urinary incontinence episodes between the baseline and the follow-up visits.
Figure 3
Figure 3
I-QoL, UDI-6, and IIQ-7 score changes between week 0 and week 8 of treatment among both study groups. Legend: *—statistically significant difference.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Haylen B.T., Maher C.F., Barber M.D., Camargo S., Dandolu V., Digesu A., Goldman H.B., Huser M., Milani A.L., Moran P.A., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Organ Prolapse (POP) Int. Urogynecol. J. 2016;27:165–194. doi: 10.1007/s00192-015-2932-1. - DOI - PubMed
    1. Irwin D.E., Milsom I., Hunskaar S., Reilly K., Kopp Z., Herschorn S., Coyne K., Kelleher C., Hampel C., Artibani W., et al. Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study. Eur. Urol. 2006;50:1306–1315. doi: 10.1016/j.eururo.2006.09.019. - DOI - PubMed
    1. Coyne K.S., Wein A.J., Tubaro A., Sexton C.C., Thompson C.L., Kopp Z.S., Aiyer L.P. The Burden of Lower Urinary Tract Symptoms: Evaluating the Effect of LUTS on Health-Related Quality of Life, Anxiety and Depression: EpiLUTS. BJU Int. 2009;103:4–11. doi: 10.1111/j.1464-410X.2009.08371.x. - DOI - PubMed
    1. Ganz M.L., Smalarz A.M., Krupski T.L., Anger J.T., Hu J.C., Wittrup-Jensen K.U., Pashos C.L. Economic Costs of Overactive Bladder in the United States. Urology. 2010;75:526–532.e1–e18. doi: 10.1016/j.urology.2009.06.096. - DOI - PubMed
    1. Coyne K.S., Wein A., Nicholson S., Kvasz M., Chen C.-I., Milsom I. Economic Burden of Urgency Urinary Incontinence in the United States: A Systematic Review. J. Manag. Care Pharm. 2014;20:130–140. doi: 10.18553/jmcp.2014.20.2.130. - DOI - PMC - PubMed

LinkOut - more resources